Infant Phototherapy Device Market Analysis: Challenges, Growth Factors, and Future Outlook

The global Infant Phototherapy Device Market is projected to reach USD 134.45 million by 2030, expanding at a CAGR of 4%.

Get FREE Sample: https://www.nextmsc.com/infant-phototherapy-device-market/request-sample

The growth of this market is driven by the increasing number of newborns, the rising prevalence of neonatal jaundice, and the effectiveness of phototherapy as a treatment for jaundice compared to alternative methods. Phototherapy is considered a safe and effective approach to managing jaundice in newborns, which further contributes to its adoption.

Despite its advantages, the market faces challenges such as the side effects associated with phototherapy and the availability of alternative treatments like IVIG treatment and exchange transfusion, which may limit the market growth. However, the growing market potential in developing regions and the increase in mergers and acquisitions within the industry is expected to create new opportunities for market players in the coming years.

North America holds the largest share of the infant phototherapy device market, attributed to factors such as a well-developed medical device industry, high rates of diagnosis and treatment of neonatal jaundice, rising consumer awareness, and access to technologically advanced treatment options.

Key market players in the industry include Atom Medical Corporation, AVI Healthcare Pvt. Ltd., Natus Medical Incorporated, Motif Medical, Little Sparrows Technologies, Ningbo David Medical Device Co., Ltd., Novos Medical Devices, General Electric Company, Ibis Medical Equipment & Systems Pvt. Ltd., Weyer GmbH, and Zhengzhou Dison Instrument and Meter Co., Ltd.